Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: More aggressive tumor behavior? Journal Article


Authors: Saud, L. R. C.; Chagas, A. L.; Maccali, C.; Pinto, P. V. A.; Horvat, N.; Alencar, R. S. S. M.; Tani, C. M.; Abdala, E.; Carrilho, F. J.
Article Title: Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: More aggressive tumor behavior?
Abstract: INTRODUCTION AND OBJECTIVES: Hepatocellular carcinoma (HCC) is the 6th cause of cancer and hepatitis C (HCV) and B (HBV) viruses are the most frequent risk factors for HCC. Patients coinfected with HCV or HBV and HIV present a faster progression to liver fibrosis and higher incidence of HCC. The aim of this study was to evaluate the survival and clinical outcomes of coinfected patients with HCC comparing with non-HIV patients. METHODS: We conducted a retrospective cohort study, including 267 HCC patients with HCV or HBV infection with or without HIV. The primary endpoint was overall survival. A Kaplan-Meier curve was presented to assess survival function. Clinical and radiologic variables, according to HIV status, were compared by logistic regression. RESULTS: Among 267 HCC patients, 25 (9.3%) were HIV-positive. In the coinfected group, patients were younger (49.8 vs 61.2 years, P < 0.001), cirrhosis was less predominant (88 vs 96.7%, P = 0.05), a smaller proportion received HCC treatment (60 vs 86.3%, P = 0.001) and the frequency of portal vein tumoral thrombosis was higher (32 vs 11.1%, P = 0.003). The overall mortality rate was higher in the HIV-positive group (92 vs 74.3%), independently of clinical and tumoral variables. CONCLUSION: Coinfected patients with HCC presented higher mortality, tumor diagnosis in a younger age, less underlying cirrhosis and a higher frequency of tumoral thrombosis. Further studies are warranted to better understand the role of HIV in hepatocarcinogenesis, in order to improve the management of those patients, particularly regarding screening programs. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Journal Title: European Journal of Gastroenterology and Hepatology
Volume: 33
Issue: 4
ISSN: 0954-691X
Publisher: Lippincott Williams & Wilkins  
Date Published: 2021-04-01
Start Page: 583
End Page: 588
Language: English
DOI: 10.1097/meg.0000000000002057
PUBMED: 33560682
PROVIDER: scopus
PMCID: PMC9446514
DOI/URL:
Notes: Article -- Export Date: 1 April 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Natally Horvat
    101 Horvat